| abstract |
The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, solvates, esters, or isomers thereof, which are useful for treating diseases or conditions mediated by LpxC. It is. The present invention relates to a new class of compounds as LpxC inhibitors, methods of preparing such compounds, pharmaceutical compositions comprising one or more such compounds, pharmaceutical formulations comprising one or more such compounds Methods of preparing the product, as well as methods of treating, preventing, suppressing or ameliorating one or more diseases associated with LpxC are provided using such compounds or pharmaceutical compositions. |